- Home
- GDHG vs SILO Comparison
GDHG vs SILO Comparison
Compare GDHG & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDHG
- SILO
- Stock Information
- Founded
- GDHG 2008
- SILO 2010
- Country
- GDHG China
- SILO United States
- Employees
- GDHG N/A
- SILO N/A
- Industry
- GDHG Services-Misc. Amusement & Recreation
- SILO Apparel
- Sector
- GDHG Consumer Discretionary
- SILO Consumer Discretionary
- Exchange
- GDHG Nasdaq
- SILO Nasdaq
- Market Cap
- GDHG 9.0M
- SILO 8.8M
- IPO Year
- GDHG 2023
- SILO N/A
- Fundamental
- Price
- GDHG $0.50
- SILO $1.08
- Analyst Decision
- GDHG
- SILO
- Analyst Count
- GDHG 0
- SILO 0
- Target Price
- GDHG N/A
- SILO N/A
- AVG Volume (30 Days)
- GDHG 4.5M
- SILO 139.6K
- Earning Date
- GDHG 04-08-2025
- SILO 05-12-2025
- Dividend Yield
- GDHG N/A
- SILO N/A
- EPS Growth
- GDHG N/A
- SILO N/A
- EPS
- GDHG N/A
- SILO N/A
- Revenue
- GDHG $22,333,251.00
- SILO $72,102.00
- Revenue This Year
- GDHG N/A
- SILO $1.86
- Revenue Next Year
- GDHG N/A
- SILO N/A
- P/E Ratio
- GDHG N/A
- SILO N/A
- Revenue Growth
- GDHG N/A
- SILO N/A
- 52 Week Low
- GDHG $0.39
- SILO $0.77
- 52 Week High
- GDHG $22.75
- SILO $4.50
- Technical
- Relative Strength Index (RSI)
- GDHG 37.98
- SILO 28.08
- Support Level
- GDHG $0.72
- SILO $1.20
- Resistance Level
- GDHG $5.25
- SILO $1.39
- Average True Range (ATR)
- GDHG 0.91
- SILO 0.09
- MACD
- GDHG -0.07
- SILO -0.02
- Stochastic Oscillator
- GDHG 2.34
- SILO 0.00
About GDHG Golden Heaven Group Holdings Ltd.
Golden Heaven Group Holdings Ltd is an offshore holding company. Through the operating entities in China, It manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. The parks offer a broad selection of exhilarating and recreational experiences, including both thrilling and family-friendly rides, water attractions, gourmet festivals, circus performances, and high-tech facilities. The parks collectively contain nearly 159 rides and attractions. The firm's revenue is generated from selling access to rides and attractions, charging fees for special event rentals, and collecting regular rental payments from commercial tenants.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.